Literature DB >> 20542480

Genetic susceptibility to breast cancer.

Nasim Mavaddat1, Antonis C Antoniou, Douglas F Easton, Montserrat Garcia-Closas.   

Abstract

Genetic and lifestyle/environmental factors are implicated in the aetiology of breast cancer. This review summarizes the current state of knowledge on rare high penetrance mutations, as well as moderate and low-penetrance genetic variants implicated in breast cancer aetiology. We summarize recent discoveries from large collaborative efforts to combine data from candidate gene studies, and to conduct genome-wide association studies (GWAS), primarily in breast cancers in the general population. These findings are compared with results from collaborative efforts aiming to identify genetic modifiers in BRCA1 and BRCA2 carriers. Breast cancer is a heterogeneous disease, and tumours from BRCA1 and BRCA2 carriers display distinct pathological characteristics when compared with tumours unselected for family history. The relationship between genetic variants and pathological subtypes of breast cancer, and the implication of discoveries of novel genetic variants to risk prediction in BRCA1/2 mutation carriers and in populations unselected for mutation carrier status, are discussed. (c) 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2010        PMID: 20542480      PMCID: PMC5527934          DOI: 10.1016/j.molonc.2010.04.011

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  171 in total

1.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.

Authors:  Bert Gold; Tomas Kirchhoff; Stefan Stefanov; James Lautenberger; Agnes Viale; Judy Garber; Eitan Friedman; Steven Narod; Adam B Olshen; Peter Gregersen; Kristi Kosarin; Adam Olsh; Julie Bergeron; Nathan A Ellis; Robert J Klein; Andrew G Clark; Larry Norton; Michael Dean; Jeff Boyd; Kenneth Offit
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-07       Impact factor: 11.205

Review 2.  Genetic susceptibility loci for breast cancer by estrogen receptor status.

Authors:  Montserrat Garcia-Closas; Stephen Chanock
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

Review 3.  Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.

Authors:  K A Phillips
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

4.  Variation in BRCA1 cancer risks by mutation position.

Authors:  Deborah Thompson; Douglas Easton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-04       Impact factor: 4.254

Review 5.  The genetic epidemiology of breast cancer genes.

Authors:  Deborah Thompson; Douglas Easton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

6.  A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers.

Authors:  Tong Sun; Yang Gao; Wen Tan; Sufang Ma; Yuankai Shi; Jiarui Yao; Yongli Guo; Ming Yang; Xuemei Zhang; Qingrun Zhang; Changqing Zeng; Dongxin Lin
Journal:  Nat Genet       Date:  2007-04-22       Impact factor: 38.330

Review 7.  Modifiers of risk of hereditary breast and ovarian cancer.

Authors:  Steven A Narod
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

8.  Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Authors:  Timothy R Rebbeck; Tara Friebel; Henry T Lynch; Susan L Neuhausen; Laura van 't Veer; Judy E Garber; Gareth R Evans; Steven A Narod; Claudine Isaacs; Ellen Matloff; Mary B Daly; Olufunmilayo I Olopade; Barbara L Weber
Journal:  J Clin Oncol       Date:  2004-02-23       Impact factor: 44.544

9.  Established breast cancer risk factors by clinically important tumour characteristics.

Authors:  M García-Closas; L A Brinton; J Lissowska; N Chatterjee; B Peplonska; W F Anderson; N Szeszenia-Dabrowska; A Bardin-Mikolajczak; W Zatonski; A Blair; Z Kalaylioglu; G Rymkiewicz; D Mazepa-Sikora; R Kordek; S Lukaszek; M E Sherman
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

10.  Prediction and interaction in complex disease genetics: experience in type 1 diabetes.

Authors:  David G Clayton
Journal:  PLoS Genet       Date:  2009-07-03       Impact factor: 5.917

View more
  133 in total

1.  Environment and genetics: Making sense of the noise.

Authors:  Anna Petherick
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

2.  On the molecular biology of breast cancer.

Authors:  Anne-Lise Børresen-Dale; Therese Sørlie; Vessela N Kristensen
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

3.  Assessing the integration of genomic medicine in genetic counseling training programs.

Authors:  Jessica Profato; Erynn S Gordon; Shannan Dixon; Andrea Kwan
Journal:  J Genet Couns       Date:  2014-01-08       Impact factor: 2.537

4.  Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.

Authors:  Mi-Ryung Han; Jirong Long; Ji-Yeob Choi; Siew-Kee Low; Sun-Seog Kweon; Ying Zheng; Qiuyin Cai; Jiajun Shi; Xingyi Guo; Keitaro Matsuo; Motoki Iwasaki; Chen-Yang Shen; Mi Kyung Kim; Wanqing Wen; Bingshan Li; Atsushi Takahashi; Min-Ho Shin; Yong-Bing Xiang; Hidemi Ito; Yoshio Kasuga; Dong-Young Noh; Koichi Matsuda; Min Ho Park; Yu-Tang Gao; Hiroji Iwata; Shoichiro Tsugane; Sue K Park; Michiaki Kubo; Xiao-Ou Shu; Daehee Kang; Wei Zheng
Journal:  Hum Mol Genet       Date:  2016-06-27       Impact factor: 6.150

5.  Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients.

Authors:  Raman Preet Kaur; Gowhar Shafi; Raja Paramjeet Singh Benipal; Anjana Munshi
Journal:  Med Oncol       Date:  2018-04-26       Impact factor: 3.064

6.  Risk factors and natural history of breast cancer in younger Chinese women.

Authors:  Winnie Yeo; Hang-Mei Lee; Amy Chan; Emily Yy Chan; Miranda Cm Chan; Keeng-Wai Chan; Sharon Ww Chan; Foon-Yiu Cheung; Polly Sy Cheung; Peter Hk Choi; Josette Sy Chor; William Wl Foo; Wing-Hong Kwan; Stephen Ck Law; Lawrence Pk Li; Janice Wh Tsang; Yuk Tung; Lorna Ls Wong; Ting-Ting Wong; Chun-Chung Yau; Tsz-Kok Yau; Benny Cy Zee
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  Correlations of common polymorphism of EVI-1 gene targeted by miRNA-206/133b with the pathogenesis of breast cancer.

Authors:  Tian-Yi Wang; Yin-Peng Huang; Ping Ma
Journal:  Tumour Biol       Date:  2014-06-17

8.  Breast Cancer in San Francisco: Disentangling Disparities at the Neighborhood Level.

Authors:  Scarlett Lin Gomez; Laura Fejerman; Alice Guan; Daphne Lichtensztajn; Debora Oh; Jennifer Jain; Li Tao; Robert A Hiatt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-23       Impact factor: 4.254

9.  Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes.

Authors:  Jie Shen; Li Yan; Song Liu; Christine B Ambrosone; Hua Zhao
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

10.  A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.

Authors:  Süleyman Bayram; Ahmet Taner Sümbül; Erdoğan Dadaş
Journal:  Tumour Biol       Date:  2015-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.